bromfenac sodium
The FDA and European approvals for Bromfenac Sodium are for use one day before and two weeks following cataract surgery for the treatment of ocular inflammation and pain. It is a nonsteroidal anti-inflammatory drug.. Reference standards of Bromfenac Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Bromfenac Sodium
[catalogue_number] => PA 02 47000
[category_ids] => ,79,80,78,70,82,
[chemical_name] =>
[weight] => 356.15
[form] => C15H11BrNNaO3
[cas] => 91714-93-1
[pslug] => 91714-93-1-bromfenac-sodium-api-pa0247000
[latest_product] => 0
[linkproducts] => 1
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 02 47000
Molecular Formula : C15H11BrNNaO3
Molecular Weight : 356.15
stdClass Object
(
[pname] => 2-Amino-3-(4-bromobenzoyl)benzoic Acid
[catalogue_number] => PA 02 47510
[category_ids] => ,79,80,76,75,78,70,82,
[chemical_name] =>
[weight] => 320.14
[form] => C14H10BrNO3
[cas] => 241496-82-2
[pslug] => 241496-82-2-2-amino-3-4-bromobenzoyl-benzoic-acid-pa0247510
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
2-Amino-3-(4-bromobenzoyl)benzoic Acid
Catalogue No.:PA 02 47510
Molecular Formula : C14H10BrNO3
Molecular Weight : 320.14
